CXC IP

CXC IP is a Montreal-based technology firm that specializes in identifying and commercializing intellectual property (IP) across multiple high-growth sectors. The company operates by investing its own capital to develop fundamental research, particularly from academic partnerships like McGill University, into actionable technological advancements. Their model focuses on securing defensible IP positions, including global patents and trade secrets, rather than traditional software-as-a-service (SaaS) scaling. By maintaining dedicated scientific teams and internal laboratory facilities, CXC manages the technology transfer process to bridge the gap between academic research and commercial applications. The company operates across various platforms, including agriculture (CXC AG), quantum computing, and antimicrobial resistance (AMR), to address critical technological needs with innovative solutions.

This approach provides value by translating cutting-edge scientific innovation into viable products that address real-world problems. By targeting large, addressable markets and collaborating with established industry partners, CXC facilitates the practical application of inventions that might otherwise remain confined to academic settings. Their work includes the development of biological solutions like biostimulants for crop yield enhancement, biocontrol agents for agricultural diseases, and biopolymer-based formulations that eliminate the need for microplastics in consumer goods. Through these efforts, the company aims to create sustainable economic and functional value for its partners and the broader industry.